BlackRock, Inc. 13D and 13G filings for Aerie Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | BlackRock Inc. BLK | 3,386,015 7.100% | -506,226 (-13.01%) | Filing |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | BlackRock Inc. BLK | 3,892,241 8.300% | 410,029 (+11.77%) | Filing |
| 2020-02-10 07:32 am Purchase | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | BlackRock Inc. BLK | 3,482,212 7.500% | 273,267 (+8.52%) | Filing |